96 related articles for article (PubMed ID: 17467290)
21. Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors.
Jäntti MH; Mandrika I; Kukkonen JP
Biochem Biophys Res Commun; 2014 Mar; 445(2):486-90. PubMed ID: 24530395
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.
Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J
Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711
[TBL] [Abstract][Full Text] [Related]
23. Novel sterically hindered cannabinoid CB1 receptor ligands.
Urbani P; Cascio MG; Ramunno A; Bisogno T; Saturnino C; Di Marzo V
Bioorg Med Chem; 2008 Aug; 16(15):7510-5. PubMed ID: 18579386
[TBL] [Abstract][Full Text] [Related]
24. Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance.
Gómez M; Hernández ML; Pazos MR; Tolón RM; Romero J; Fernández-Ruiz J
Neuroscience; 2008 May; 153(3):687-99. PubMed ID: 18400407
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of substrate transport-induced clustering of a glial glutamate transporter GLT-1 in astroglial-neuronal cultures.
Nakagawa T; Otsubo Y; Yatani Y; Shirakawa H; Kaneko S
Eur J Neurosci; 2008 Nov; 28(9):1719-30. PubMed ID: 18973588
[TBL] [Abstract][Full Text] [Related]
26. Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor.
Oddi S; Dainese E; Fezza F; Lanuti M; Barcaroli D; De Laurenzi V; Centonze D; Maccarrone M
J Neurochem; 2011 Mar; 116(5):858-65. PubMed ID: 21214565
[TBL] [Abstract][Full Text] [Related]
27. Green fluorescent proteins in receptor research: an emerging tool for drug discovery.
Arun KH; Kaul CL; Ramarao P
J Pharmacol Toxicol Methods; 2005; 51(1):1-23. PubMed ID: 15596111
[TBL] [Abstract][Full Text] [Related]
28. CB1-cannabinoid receptors are involved in the modulation of non-synaptic [3H]serotonin release from the rat hippocampus.
Balázsa T; Bíró J; Gullai N; Ledent C; Sperlágh B
Neurochem Int; 2008 Jan; 52(1-2):95-102. PubMed ID: 17719142
[TBL] [Abstract][Full Text] [Related]
29. Oxadiazole-diarylpyrazole 4-carboxamides as cannabinoid CB1 receptor ligands.
Lee SH; Seo HJ; Kim MJ; Kang SY; Song KS; Lee SH; Jung ME; Kim J; Lee J
Bioorg Med Chem Lett; 2009 Apr; 19(7):1899-902. PubMed ID: 19269817
[TBL] [Abstract][Full Text] [Related]
30. A di-acidic sequence motif enhances the surface expression of the potassium channel TASK-3.
Zuzarte M; Rinné S; Schlichthörl G; Schubert A; Daut J; Preisig-Müller R
Traffic; 2007 Aug; 8(8):1093-100. PubMed ID: 17547699
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging.
Yao BB; Hsieh G; Daza AV; Fan Y; Grayson GK; Garrison TR; El Kouhen O; Hooker BA; Pai M; Wensink EJ; Salyers AK; Chandran P; Zhu CZ; Zhong C; Ryther K; Gallagher ME; Chin CL; Tovcimak AE; Hradil VP; Fox GB; Dart MJ; Honore P; Meyer MD
J Pharmacol Exp Ther; 2009 Jan; 328(1):141-51. PubMed ID: 18931146
[TBL] [Abstract][Full Text] [Related]
32. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
33. A novel high-throughput assay for the quantitative assessment of receptor trafficking.
Grimsey NL; Narayan PJ; Dragunow M; Glass M
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1377-82. PubMed ID: 18565191
[TBL] [Abstract][Full Text] [Related]
34. Purification of Functional CB
Fay JF; Farrens DL
Methods Enzymol; 2017; 593():343-370. PubMed ID: 28750810
[TBL] [Abstract][Full Text] [Related]
35. Real-time imaging of green fluorescent protein-tagged beta 2-adrenergic receptor distribution in living cells.
Sunaguchi M; Nishi M; Mizobe T; Kawata M
Brain Res; 2003 Sep; 984(1-2):21-32. PubMed ID: 12932836
[TBL] [Abstract][Full Text] [Related]
36. Activation-dependent plasticity of polarized GPCR distribution on the neuronal surface.
Simon AC; Loverdo C; Gaffuri AL; Urbanski M; Ladarre D; Carrel D; Rivals I; Leterrier C; Benichou O; Dournaud P; Szabo B; Voituriez R; Lenkei Z
J Mol Cell Biol; 2013 Aug; 5(4):250-65. PubMed ID: 23585691
[TBL] [Abstract][Full Text] [Related]
37. Live-cell imaging with EosFP and other photoactivatable marker proteins of the GFP family.
Wiedenmann J; Nienhaus GU
Expert Rev Proteomics; 2006 Jun; 3(3):361-74. PubMed ID: 16771707
[TBL] [Abstract][Full Text] [Related]
38. What's for lunch at the conformational cafeteria?
Clarke WP
Mol Pharmacol; 2005 Jun; 67(6):1819-21. PubMed ID: 15784844
[TBL] [Abstract][Full Text] [Related]
39. Cell Type-Specific Tandem Affinity Purification of the Mouse Hippocampal CB1 Receptor-Associated Proteome.
Mattheus T; Kukla K; Zimmermann T; Tenzer S; Lutz B
J Proteome Res; 2016 Oct; 15(10):3585-3601. PubMed ID: 27596989
[TBL] [Abstract][Full Text] [Related]
40. Organized cannabinoid receptor distribution in neurons revealed by super-resolution fluorescence imaging.
Li H; Yang J; Tian C; Diao M; Wang Q; Zhao S; Li S; Tan F; Hua T; Qin Y; Lin CP; Deska-Gauthier D; Thompson GJ; Zhang Y; Shui W; Liu ZJ; Wang T; Zhong G
Nat Commun; 2020 Nov; 11(1):5699. PubMed ID: 33177502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
